Healthpeak Properties Inc

DOC is in a mid-range consolidation within a Stage 3 distribution phase, with bearish medium-term bias driven by a clear lower-high/lower-low structure and price trading below declining EMAs. Short-term momentum remains weak, so execution favors selling now into resistance around the 9- and 20-day EMAs (20.62–20.87), while the long-term uptrend above the 200-day SMA provides structural support.

• ↑Q2 2026 revenue increased 35% YoY to $771.58 M with net income at $52.82 M
• ↑Adjusted FFO guidance raised to $1.73–$1.77 per share for 2026
• ↓Earnings yield is negative and profitability factors remain weak